Connect with us

Hi, what are you looking for?

Uncategorized

AnPac Bio Commences Proposed Public Offering of American Depositary Shares

SUNRISE, Fla., Nov. 09, 2021 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC, the “Company”)), a biotechnology company with operations in China and the United States focusing on early cancer screening and detection, today announced it has commenced an underwritten public offering of its American Depositary Shares (“ADSs”). EF Hutton, division of Benchmark Investments, LLC, is acting as the sole book-running manager for the offering.

The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. A registration statement on Form F-3 (File No. 333-256630) relating to the securities was filed with the U.S. Securities and Exchange Commission on May 28, 2021 and declared effective on June 7, 2021.

The offering is being made only by means of a prospectus supplement and accompany prospectus. A prospectus supplement describing the terms of the public offering will be filed with the SEC and will form a part of the effective registration statement.

Copies of the prospectus supplement and …

Full story available on Benzinga.com

Original Post: benzinga.com

Click to comment

Leave a Reply

Your email address will not be published.

You May Also Like

World247News.com